Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases

18Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Neural stem cells (NSCs) led to the development of a novel strategy for delivering therapeutic genes to brain tumors. Human NSCs expressing rabbit carboxyl esterase (F3.CE), which activates CPT-11, significantly inhibit the growth of A549 human non-small cell lung adenocarcinoma cells in the presence of CPT-11 in vitro and in vivo. F3.CE cells migrated selectively into the brain metastases located in the opposite hemisphere. The treatment also significantly decreased tumor volume in immune-deficient mice bearing lung cancer when F3.CE cells were transplanted into the contralateral hemisphere. The survival of tumor-bearing animals was significantly prolonged by the treatment with F3.CE and CPT-11. This strategy could be considered as an effective treatment regimen for lung cancer brain metastases. © 2013 Nature America, Inc.

Cite

CITATION STYLE

APA

Hong, S. H., Lee, H. J., An, J., Lim, I., Borlongan, C., Aboody, K. S., & Kim, S. U. (2013). Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases. Cancer Gene Therapy, 20(12), 678–682. https://doi.org/10.1038/cgt.2013.69

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free